HIGHLIGHTS
- who: Daniel A. Mohl et al. from the University of Freiburg, Freiburg, Germany have published the Article: Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma, in the Journal: Cells 2023, 12, 1102. of /2023/
- what: The aim of this work was to determine whether there are any metabolic differences between normal (PEC) and cancer cells (VPR) regarding modified nucleosides and to discover potential candidates for novel biomarkers for ccRCC. For the analysis of variance (ANOVA), a q-value of 0.05 was used, which was obtained . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.